LS BioPath Overview

  • Founded
  • 2007

Founded
  • Status
  • Private

  • Latest Deal Type
  • Series C

  • Latest Deal Amount
  • $6.94M

LS BioPath General Information

Description

Developer of intra-operative imaging device designed for diagnosing breast cancer. The company's simple to operate battery-operated, handheld imaging device de-couples signatures of abnormal from normal tissue during breast cancer surgery and displays them on the device screen, enabling doctors to identify breast tissue abnormalities and reduce the need for repeat surgeries.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Primary Office
  • 18809 Cox Avenue
  • Suite 140
  • Saratoga, CA 95070
  • United States
+1 (408) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

LS BioPath Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series C) 06-Jul-2021 $6.94M 00.000 000.00 Completed Generating Revenue
2. Early Stage VC (Series B) 10-Mar-2011 00.00 00.00 000.00 Completed Startup
1. Early Stage VC (Series A) 25-Nov-2009 $700K $700K 00.00 Completed Startup
To view LS BioPath’s complete valuation and funding history, request access »

LS BioPath Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C 0,000,000 00.000000 00.0 00.0 00 00.0 00.000
Series B 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series A 3,000,000 $0.001000 $0.35 $0.35 1x $0.35 13.81%
To view LS BioPath’s complete cap table history, request access »

LS BioPath Patents

LS BioPath Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20130230883-A1 Methods for detection and characterization of abnormal tissue and cells using an electrical system Granted 01-Feb-2007 000000000
US-8865076-B2 Methods for detection and characterization of abnormal tissue and cells using an electrical system Active 01-Feb-2007 000000000
US-8417328-B2 Electrical systems for detection and characterization of abnormal tissue and cells Active 01-Feb-2007 000000000 00
US-8437845-B2 Electrical methods for detection and characterization of abnormal tissue and cells Active 01-Feb-2007 000000000
US-20100106047-A1 Electrical methods for detection and characterization of abnormal tissue and cells Granted 01-Feb-2007 A61B5/418
To view LS BioPath’s complete patent history, request access »

LS BioPath Executive Team (3)

Name Title Board Seat Contact Info
Moshe Sarfaty Chief Executive Officer
Rusmin Kudinar Chief Operating Officer & Board Member
You’re viewing 2 of 3 executive team members. Get the full list »

LS BioPath Board Members (4)

Name Representing Role Since
Jeff Donnelly LS BioPath Board Member 000 0000
Jim Pfeiffer LS BioPath Board Member 000 0000
Rusmin Kudinar LS BioPath Chief Operating Officer & Board Member 000 0000
You’re viewing 3 of 4 board members. Get the full list »